AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub
May 17, 2022 22:03 ET | AGC Biologics
SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector...
AquaBounty_Blue_Flat_SPOT2995_FINAL.png
AquaBounty Announces Adjournment of Annual Meeting of Stockholders until May 27, 2022
May 17, 2022 16:05 ET | AquaBounty Technologies, Inc.
MAYNARD, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conference
May 17, 2022 16:01 ET | MacroGenics, Inc.
ROCKVILLE, MD, May 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics to Participate in the 2022 H.C. Wainwright Global Life Sciences Conference
May 17, 2022 16:00 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to...
The Context Network Expands Leadership Team
May 17, 2022 11:16 ET | The Context Network
WEST DES MOINES, Iowa, May 17, 2022 (GLOBE NEWSWIRE) -- The Context Network (Context), an agribusiness consulting firm, has expanded its leadership team, naming Kellie Gypin and Kris Pauna as new...
Datavant _ BlueBlack (3) (1).png
Data Unveil Partners with Datavant to Augment Biopharma Commercial Insights
May 17, 2022 08:55 ET | Datavant
SAN FRANCISCO, May 17, 2022 (GLOBE NEWSWIRE) -- Data Unveil, a technology platform firm dedicated to helping life sciences clients better utilize the valuable data they receive from their commercial...
Madrigal logo.jpg
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
May 17, 2022 08:00 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic...
PDS Biotech Logo.png
PDS Biotech to Participate at Upcoming Investor Conferences
May 17, 2022 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Provides Regulatory Update Related to New Drug Application for Omecamtiv Mecarbil
May 17, 2022 07:30 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the Company recently participated in a mid-cycle communication meeting with...
Stacked logo.png
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery
May 17, 2022 02:30 ET | Sosei Group Corporation
Collaboration is part of Sosei Heptares’ Target Identification and Validation (TIV) strategy to leverage multiple sophisticated technologies that drive creation of new drug discovery programs in key...